We are now in crisis again because of Donald Trump’s executive order freezing aid. Surely local drug manufacture now needs to be implemented without any further delay?

A new survey from the ABPI has revealed a surge in apprenticeships, placements and global research collaborations in the UK ...

DMU will be part of a consortium laying the foundation for future medicines that are affordable, safe, effective, and ...

The TriNetX-Fujitsu joint venture aligns with the growing number of Japanese medical institutions joining the TriNetX network. Researchers are already conducting novel studies using TriNetX data and ...

We think its portfolio and pipeline support a wide moat, and with the HCV market stabilizing, Gilead needs strong continued innovation in HIV, solid oncology pipeline data, and smart future ...

Today, adoption of digital health faces some of the same barriers — scepticism, budget limitations, high expectations, and a ...

JuliaHub simplifies complex pharmaceutical workflows by integrating analytics such as modeling and simulation in pharmacometrics. Unlike fragmented systems, it ensures seamless transitions between ...

Pharmaceutical company Takeda is pioneering a technology-enabled, patient-centered future for plasma-derived therapies ...

The finest minds from the pharma firmament will also be sharing insights on the changing landscape and on the new imperatives ...

Johnson & Johnson — leaders in healthcare innovation, where treatments are smarter and less invasive, and solutions are ...

Royalty Pharma to provide R&D investment of up to $250 million for Biogen's litifilimab, a potential first-in-class biologic in Phase 3 development for the treatment of lupus. NEW ...

In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...